CAS 151213-40-0
:(4aS,7aS)-Ottaidro-1H-pirrolo[3,4-b]piridina
Formula:C7H14N2
InChI:InChI=1S/C7H14N2/c1-2-6-4-8-5-7(6)9-3-1/h6-9H,1-5H2/t6-,7+/m0/s1
InChI key:InChIKey=KSCPLKVBWDOSAI-NKWVEPMBSA-N
SMILES:[C@]12([C@@](CNC1)(NCCC2)[H])[H]
Sinonimi:- (1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
- (1S,6S)-cis-2,8-Diazabicyclo[4.3.0]nonane
- (4AS,7aS)-Octahydro-1H-pyrrole[3,4-b]pyridine
- (4aS,7aS)-2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride
- (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine
- (S,S)-2,8-Diazabicyclo[4,3,0]Nonane
- (S,S)-2,8-Diazabicyclo[4,3,0]Onoane
- (S,S)-2,8-Diazabicylco(4,3,0)Nonane
- 1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-
- 1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS-cis)-
- Cis-Octahydropyrrolo[3,4-B]Pyridine
- Moxifloxacin side chain
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 10 prodotti.
(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:Formula:C7H14N2Purezza:>98.0%(GC)Colore e forma:Colorless to Light orange to Yellow clear liquidPeso molecolare:126.201H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-
CAS:Formula:C7H14N2Purezza:97%Colore e forma:LiquidPeso molecolare:126.1995(1S,6S)-2,8-Diazabicyclo[4.3.0]Nonane
CAS:(1S,6S)-2,8-Diazabicyclo[4.3.0]NonaneFormula:C7H14N2Purezza:98%Peso molecolare:126.2(S,S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridineFormula:C7H14N2Purezza:97%Peso molecolare:126.2Ref: 4Z-M-27103
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta(S,S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:Prodotto controllatoApplications Moxifloxacin intermediate
Formula:C7H14N2Colore e forma:NeatPeso molecolare:126.2(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane is a chiral compound that can be made from the reaction of an organic acid with an amino alcohol. The enantiomers of this compound have shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. The synthetic process for this compound was originally developed in the 1980s by researchers at the University of Illinois. They were able to show that it was possible to make a carbonyl reduction product using imidodicarbonic acid and an organic solvent. This led to the synthesis of moxifloxacin hydrochloride, which is used as a treatment for bacterial infections such as tuberculosis or pneumonia.Formula:C7H14N2Purezza:Min. 95%Colore e forma:Colourless To Brown LiquidPeso molecolare:126.2 g/molRef: ST-EA-CP-M26100
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta









